Neonatal Intensive Care Respiratory Devices Market By Device Type (Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Pressure Devices, Apnea Monitors, and Others), By End-user (NICU Hospitals, Specialty Clinics, Nursing Homes, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI425320 | Publish Date: April 2024 | No. of Pages: 180

Global Neonatal Intensive Care Respiratory Devices Market Overview

Neonatal respiratory care includes nursing and treating newborn babies suffering from breathing disorders. A neonatal intensive care unit is also called as a newborn intensive care unit (NICU) or intensive care nursery (ICN). NICU is equipped with blood pressure monitor, incubators, ventilator, oxygen hood, and other equipment. Newborn babies who require intensive care are mainly admitted to the NICU. The NICU is equipped with wide range of respiratory devices which plays a vital role in treating respiratory disorders and other equipment to take care of the babies. Moreover, demand for neonatal intensive care respiratory devices is expected to fall over the forecast period due to high cost and technical errors in NICU devices. Neonatal intensive care respiratory devices market accounted for US$ 6.7 billion in 2020 and is estimated to be US$ 12.97 billion by 2030 and is anticipated to register a CAGR of 6.9%.

Global Neonatal Intensive Care Respiratory Devices Market Drivers & Restraints

Drivers: High incidence rate of respiratory diseases in newborn babies

Growth in prevalence of respiratory diseases in newborn babies and growing incidence of preterm births coupled with corresponding efforts to improve survival rates are likely to propel the growth of the global market over the forecast period. According to the data reported by WHO, 2.7 million stillbirths and 3.1 million neonatal deaths occur every year across the globe. This has attributed to raise the demand for neonatal intensive care centers. Additionally, healthcare-associated infections and neonatal hospital-acquired infections such as Central Line-Associated Bloodstream Infections (CLABSI) are some factors that are boost the growth of the market.

Supportive government initiatives

Supportive government initiatives, especially in developing countries, will boost the target market development. Key players and Manufacturers in emerging economies, such as India and China, are focusing on creating non-invasive, cost-efficient neonatal intensive care respiratory devices to meet the local needs and provide flexibility in patient care. Developments, in terms of design, efficiency, and safety resulted in substantial benefits, such as better gas exchange, improved weaning, better oxygenation, and lower damage to the lungs.

However, rising costs of neonatal intensive care respiratory devices and growing incidence of ventilator-associated pneumonia are expected to limit the target market growth.

Global Neonatal Intensive Care Respiratory Devices Market Segmentations & Regional Insights

Neonatal intensive care respiratory devices market is segmented based on device type, end-user, and region.

On the basis of device type, the neonatal intensive care respiratory devices market is segmented into nebulizers, inhalers, ventilators, continuous positive airway pressure devices, apnea monitors, and others. Based on end-user, the target market is segmented into NICU hospitals, specialty clinics, nursing homes, others

Regional Insights:

The neonatal intensive care respiratory devices market accounted for US$ 6.7 billion in 2020 and is estimated to be US$ 12.97 billion by 2030 and is anticipated to register a CAGR of 6.9%. On region the Neonatal intensive care respiratory devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to witness for major share of the neonatal intensive care respiratory devices market in 2018, owing to growth in prevalence of premature births and high cost of technologically advanced respiratory devices. Factors such as increase in R&D activities and government initiatives to spread awareness about neonatal diseases drives the target market in the region. Additionally, rapid adoption of new devices, high prices of products, and growth in incidence of premature births in the U.S. propels the growth of the neonatal intensive care respiratory devices market in North America. According to data published by WHO in 2016, the U.S. placed sixth in the world in premature births. As per the study released by the FDA (2016), around 6% of 4 million births in the U.S. per year requires NICU admission and majority of them is due to preterm birth. Asia Pacific neonatal intensive care respiratory devices market is estimated to grow at a high CAGR over the forecast period owing to high preterm rate, growth in development of health care infrastructure by both public and private hospitals, and surge in the number of NICU beds in countries such as South Korea and China.

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Device type - Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Pressure Devices, Apnea Monitors, and Others

By End-user– NICU Hospitals, Specialty Clinics, Nursing Homes, Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the neonatal intensive care respiratory devices market report based on devices, end users and region.

Neonatal Intensive Care Respiratory Devices Market Segmentation

Neonatal Intensive Care Respiratory Devices Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global Neonatal Intensive Care Respiratory Devices Market Competitive Landscape & Key Players

The key players operating the neonatal intensive care respiratory devices market includes GE Healthcare, Covidien, Getinge Group, Philips Healthcare, Draegerwerk AG, Teleflex Inc., AstraZeneca, Endo International, Johnson & Johnson, and Pfizer. Additionally, Medtronic plc, Cook Medical, and Becton, Dickinson and The Company are the top three leading players of the market. These key players are entering into joint ventures, mergers and acquisitions with local and regional suppliers in order to expand their revenue and development activities. Further, introduce new products and expand worldwide.

Global Neonatal Intensive Care Respiratory Devices Market Company Profile

  • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Covidien
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Getinge Group
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Philips Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Draegerwerk AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Teleflex Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Endo International
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

FAQs

The global neonatal intensive care respiratory devices market is segmented based on device type, end-user, and region.

The high incidence rate of respiratory diseases in newborn babies is the major factor driving the global neonatal intensive care respiratory devices market growth.

North America is estimated to witness a major share of the global neonatal intensive care respiratory devices market in 2018, owing to the growth in the prevalence of premature births and the high cost of technologically advanced respiratory devices.

Medtronic plc, Cook Medical, and Becton, Dickinson, and The Company are the top three leading players of the market. These key players are entering into joint ventures, mergers, and acquisitions with local and regional suppliers in order to expand their revenue and development activities. Further, introduce new products and expand worldwide.